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Abstract  
 
The familial aggregation of Major Depressive Disorder (MDD) has been repeatedly demonstrated. 
Several studies have investigated associations between various clinical characteristics of MDD in 
probands and overall rates of MDD in relatives. Few studies, however, have considered the familial 
aggregation of clinical characteristics of MDD. The aim of the present report is to examine mother–
offspring associations of a variety of clinical characteristics of MDD in a general population sample. 
Data were derived from baseline and 4-year-follow-up data of 933 adolescents and their biological 
mothers of the Early Developmental Stages of Psychopathology (EDSP) study, a prospective-
longitudinal community study. MDD and its characteristics were assessed with the Munich-Composite 
International Diagnostic Interview. We found that children of mothers who had a lifetime history of 
severe MDD and high number of symptoms, high impairment and/or melancholia, revealed elevated 
odds of MDD regarding the same characteristics as their mothers (ORs between 5.2 and 13.9). The 
observed associations did not differ by the children’s sex. DSM-IV melancholia and severity as well as 
impairment were found to aggregate within families. This finding can be interpreted as a validation of 
the DSM-IV MDD severity subtypes as well as of the melancholic specifier. Severe and melancholic 
MDD reveal a considerable high degree of familiar aggregation making the search for mechanisms 
involved in the familiar transmission of these forms of MDD particularly promising.   
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1. Introduction  
 
Accumulating research over the last decades suggests phenotypic as well as etiologic 
heterogeneity of Major Depressive Disorder (MDD) (Barondes, 1999; Merikangas et al., 
2002). For example, the clinical presentation of MDD can vary considerably with respect to 
symptomatology, age at onset, duration, or severity. In family- genetic studies, more 
homogeneous subgroups of mental disorders can be identified through studying the patterns 
of familial aggregation associated with different clinical features of MDD (Weissman et al., 
1986a,b; Sullivan et al., 2000; Merikangas et al., 2002).  
 
The overall familial aggregation of MDD has been repeatedly demonstrated (Klein et al., 
2001; Lieb et al., 2002b; for a review, see Sullivan et al., 2000). Yet, the question whether this 
aggregation differs for various MDD subgroups has yielded more contradicting research 
results. Most studies have examined whether certain clinical characteristics of MDD in the 
probands predicted MDD in relatives. For example, Lieb et al. (2002a) demonstrated that 
recurrence and impairment as clinical characteristics of MDD in adolescents were associated 
with elevated rates of MDD in their parents (see also Bland et al., 1986; Weissman et al., 
1986a,b; Maier et al., 1991; Kendler et al., 1994, 1999; Wickramaratne et al., 2000; Klein et 
al., 2002). Other characteristics that have been studied in family or twin studies are age at 
onset (Mendlewicz and Baron, 1981; Gershon et al., 1982; Weissman et al., 1984; Bland et 
al., 1986; McGuffin et al., 1987; Price et al., 1987; Stancer et al., 1987; Weissman et al., 
1988; Kupfer et al., 1989; Maier et al., 1991; Kendler et al., 1994; Harrington et al., 1997; 
Wickramaratne and Weissman, 1998; Kendler et al., 1999; Wickramaratne et al., 2000; Klein 
et al., 2002; Lieb et al., 2002a), severity (Klein et al., 2002; Lieb et al., 2002a; Hammen and 
Brennan, 2003), treatment (Weissman et al., 1986a,b; Kendler et al., 1994; Klein et al., 2002; 
Lieb et al., 2002a), comorbidity (Weissman et al., 1986a,b; Kendler et al., 1994; Lieb et al., 
2002a), as well as specific depressive symptomatology, for example, suicidality or 
melancholia (Leckman et al., 1984a,b; Weissman et al., 1986a,b; Klein, 1990; Kendler, 1997; 
Kendler et al., 1994, 1999; Klein et al., 2002; Lieb et al., 2002a).  
 
One important but rather understudied aspect in this context is whether certain characteristics 
of MDD aggregate within families. If specific clinical variables of MDD can be identified to 
„breed true“, this could mark distinct subgroups of MDD which are transmitted in families. 
This is an extension of the research described above insofar as here clinical characteristics are 
taken into consideration in all the family members. However, this requires detailed 
information on various aspects of MDD not only in the probands but also in the relatives. We 
identified few studies dealing with this question. Klein et al. (2002), for example, found no 
familial aggregation of the MDD features severity, recurrence, chronicity, early onset, 
impairment, melancholia, suicidality, and treatment among adolescents and their first-degree 
relatives with MDD. Leckman et al. (1984b) were not able to demonstrate that various 
subtypes of MDD „breed true“ within families. With respect to an early onset of MDD, 
Wickramaratne and Weissman (1998) found elevated rates of childhood-onset MDD only in 
children of parents with early-onset of MDD (see also Weissman et al., 1986a,b, 1988; Maier 
et al., 1991). Between twins concordant for MDD, Kendler et al. (1992) reported significant 
but minor relations as regards age at onset, treatment seeking, impairment, number of 
symptoms and suicidal ideation, but no relations as regards melancholia (Kendler, 1997).  
 
Several limitations of previous studies must be considered: Only two (Kendler et al., 1992; 
Klein et al., 2002) included a variety of characteristics simultaneously. As most of these 
studies were based on clinical samples, extrapolation to the general population cannot be 
made (Kendler, 1995). Furthermore, in the majority of the studies, family history information 
was used rather than direct diagnostic interviews. In addition, the definitions of MDD 
characteristics vary considerably among studies.  
 
The aim of the present report is to study the familial aggregation of MDD by taking into 
consideration different clinical characteristics of MDD. We examined associations between 
clinical characteristics of MDD in mothers and their children from a representative 
community sample. Our analyses were restricted to mothers and their children because for 
other family members no direct diagnostic information allowing for detailed information on 
characteristics of MDD was available. This paper is an extension of our previously published 
results in that we consider characteristics of MDD in probands as well as in relatives 
(mothers). In our previous work, overall rates of familial MDD associated with certain 
characteristics of MDD in the probands were examined (Lieb et al., 2002a). The specific 
questions are as follows: (1) How frequent are MDD and its characteristics in the mothers and 
their children, and (2) do mothers and children with MDD resemble each other with respect to 
characteristics of MDD, i.e., can we find mother–offspring associations between clinical 
characteristics of MDD?  
 
2. Methods  
 
2.1. Design  
 
Data come from the Early Developmental Stages of Psychopathology study (EDSP). The 
EDSP is a prospective- longitudinal survey to collect data on the prevalence and incidence, 
familial and other risk factors, comorbidity, and course of mental disorders in a representative 
sample of originally 3021 participants 14–24 years of age. The study consists of a baseline 
and two follow-up investigations. The parents of the 14- to 17- year-olds at baseline were 
additionally assessed in a separate parent survey. Detailed descriptions of the EDSP design 
and field procedures are reported elsewhere (Wittchen et al., 1998a; Lieb et al., 2000).  
 
2.2. Sample  
 
The EDSP builds on a random population sample from the 1994 government population 
registries of residents in Munich, Germany. As the study was designed with special interest in 
early developmental stages of psychopathology, 14- to 15-year-olds were sampled at twice the 
probability of 16- to 21-year-olds, and 22- to 24-yearolds were sampled at half this 
probability. Details about the sampling, representativeness, and sociodemographic 
characteristics of the whole EDSP-sample have been reported (Wittchen et al., 1998a; Lieb et 
al., 2000). At baseline (T0), the response rate for the study sample of 14- to 17-year-olds (the 
„younger cohort“) was 74.3%. The first follow-up study (T1) was conducted an average of 
19.7 months (range = 15–25.6 months; 88.0% response rate among baseline responders), and 
the second follow-up study (T2) was conducted an average of 42 months (range = 34–50 
months; 83.8% response rate among baseline responders) after the baseline investigation.  
 
In the parent survey, information about early development and familial psychopathology was 
obtained in direct diagnostic interviews with the parents of the younger cohort (Lieb et al., 
2000). Fathers were interviewed only if the mother was not available (deceased or not 
located). The parents of 1053 adolescents were interviewed directly (in 1026 cases the 
mother, in 27 cases the father; 86.0% response rate among T1 responders). The predominant 
causes of non-response among parents were their refusal to participate (12.9%), researchers’ 
failure to contact parents (0.7%), and parents’ lack of time (0.5%; see Lieb et al., 2000). The 
study sample for the current report consisted of all adolescents who had completed the second 
follow-up and whose biological mothers had participated in the parent survey (N = 933). 
These adolescents represent the offspring for the following report. For a detailed overview of 
the EDSP study design including the sample of the present report see Höfler et al. (2005).  
 
We decided to limit the analyses to this sample for the following reasons: (1) information on 
clinical characteristics of MDD was available only for parents directly interviewed in the 
parent investigation, (2) of these 1053 interviews only 27 were conducted with fathers and 
eight with non-biological mothers. To make interpretation of the results clearer we included 
only the biological mothers and their adolescents, and (3) only those adolescents were 
included who completed the second follow-up investigation in order to take advantage of the 
information of the complete follow-up period. Analyses were conducted to evaluate whether 
there was a systematic drop-out based on DSM-IV diagnoses of affective, anxiety or 
substance use disorders or sociodemographic variables from 1395 individuals of the younger 
cohort at baseline to 933 in the sample of the present report. It could be demonstrated that no 
major bias is expected (Höfler et al., 2005; Schreier, 2005).  
 
2.3. Assessment  
 
Adolescents and their parents were assessed with the computer-assisted version of the 
Munich-Composite International Diagnostic Interview (DIA-X/M-CIDI; Wittchen and Pfister, 
1997), an updated version of the World Health Organization’s (WHO) Composite 
International Diagnostic Interview version 1.2 (World Health Organization, 1990). Diagnostic 
findings – according to the explicit diagnostic criteria of the Diagnostic and Statistical Manual 
of Mental Disorders, 4th revision (DSM-IV; American Psychiatric Association [APA], 1994) 
– were obtained by using the M-CIDI/DSM-IV algorithms. For a detailed discussion of the 
M-CIDI, see Wittchen et al. (1998b) and Lachner et al. (1998). The reliability and validity of 
the M-CIDI and its assessment of MDD, along with descriptions of the M-CIDI format and 
coding conventions, have been presented by Wittchen et al. (1998b) and Reed et al. (1998). In 
all assessments, the M-CIDI was supplemented by a separate booklet that included several 
scales and questionnaires to assess psychological constructs relevant to the study. All 
interviews were administered by highly trained clinical interviewers. Most interviews were 
carried out in the homes of the adolescents and their parents. A detailed overview and 
characterization of the constructs and assessment methods have been provided elsewhere 
(Höfler et al., 1999; Wittchen et al., 1999; Lieb et al., 2000). At baseline, the lifetime version 
of the MCIDI was used. At each of the follow-up assessments, we applied the M-CIDI 
interval version, which refers to the time period between the last and the present interview. 
For the study sample to be considered in the following report, the complete lifetime status 
until T2 was assessed from the aggregation of information obtained from the T0, T1, and T2 
interviews.  
 
2.4. Assessment of MDD and MDD characteristics  
 
All the diagnostic information on MDD and its characteristics in the adolescents and their 
mothers was collected within the M-CIDI depression section (see Oldehinkel et al., 1999). 
Diagnoses were obtained by using the M-CIDI diagnostic package for DSM-IV diagnostic 
algorithms. The clinical characteristics of MDD were defined as follows: (1) Severity of 
MDD symptoms according to DSM-IV specifications allowing for subtyping mild, moderate, 
and severe forms. In the analyses, severe MDD was compared to the collapsed category of 
mild and moderate MDD; (2) recurrence as more than one episode of MDD; (3) early onset 
based on self-reported age at onset of depressive symptoms (cut-offs: adolescents: before age 
15; mothers: before age 30); (4) impairment in daily life and activities due to MDD during the 
worst episode. The answers „very much“ and „a lot“ were collapsed and compared to the 
combined category of „not at all“ and „somewhat“; (5) treatment of MDD by a doctor, 
another specialist, or in hospital; (6) suicidality as presence of suicidal attempts, ideas, or 
plans; (7) melancholia according to DSM-IV; (8) comorbidity as presence of any DSM-IV 
anxiety disorder (lifetime), including panic disorder, agoraphobia, phobia NOS, social phobia, 
specific phobia, generalized anxiety disorder, obsessive compulsive disorder, and 
posttraumatic stress disorder; and (9) at least 7 symptoms versus 5 or 6 symptoms according 
to the DSM-IV criteria for MDD during the worst episode (range = 5–9 among MDD cases).  
 
In the following, mothers with MDD who fulfilled the conditions for a certain MDD 
characteristic will be referred to as „MDD Charac +“ mothers. Mothers who fulfilled the 
criteria for MDD but did not fulfill the definition of the respective characteristic will be 
referred to as „MDD Charac –“ mothers.  
 
2.5. Statistical analyses  
 
Data were weighted to consider different sampling probabilities as well as systematic non-
response at baseline and first follow-up according to age, sex, and geographic distribution. 
For our analyses we used the Stata software package (StataCorp., 2003) and applied the 
Huber–White sandwich matrix for robust estimates of confidence intervals in the case of 
weighted data (Royall, 1986).  
 
As the aim was to examine the degree to which maternal characteristics of MDD predict 
characteristics of MDD in children, the maternal status regarding MDD and characteristics of 
MDD was the independent variable. Diagnostic outcomes were the offspring’s cumulative 
lifetime incidence rates of MDD and lifetime presence of MDD characteristics (assessed at 
T0, T1, and T2).  
 
The associations between maternal MDD characteristics and MDD characteristics in children 
were estimated with odds ratios (ORs) from logistic regressions (McCullagh and Nelder, 
1989). The reference group consisted of those children with MDD who did not fulfill the 
criteria for the particular characteristic.  
 
Sex and age of offspring were controlled for in all analyses. All analyses were repeated by 
additionally controlling for sociodemographic variables in mothers. This was done to see to 
what extent these variables may alter the observed associations. To examine possible gender 
heterogeneity in the differences, we additionally assessed interactions with sex of offspring. 
Throughout the paper, a p-value <0.05 was considered as statistically significant.  
 
3. Results  
 
3.1. Lifetime prevalence of MDD and frequency of MDD characteristics in mothers and 
children  
 
About one fifth of the mothers (N = 188; weighted percentage [%w] = 19.5; 95% confidence 
interval [CI] = 16.9– 22.4) and about 14% of the adolescents (N = 126; %w = 13.9; 95% CI = 
11.5–16.5) reported to have ever fulfilled the criteria for MDD. MDD was more common in 
female than in male offspring (17% vs. 11%; OR = 1.7; 95% CI = 1.1–2.7). There were N = 
33 (%w = 3.6; 95% CI = 2.3–5.2) mother–child pairs affected by MDD.  
 
In Table 1, the frequencies of MDD characteristics are presented for mothers and their 
children. For most characteristics, the rates are similar in mothers and children. For example, 
more than 80% of the mothers and children With MDD reported that they were impaired by 
the symptoms, and about 50% also fulfilled the lifetime criteria for any comorbid DSM-IV 
anxiety disorder. However, only 24.2% of the children, as compared to almost two thirds of 
the mothers, had received treatment of their depression. Male and female offspring did not 
differ with respect to the frequency of the different MDD characteristics.  
 
3.2. Sociodemographic characteristics of mothers and children  
 
With respect to their mean age, mothers with MDD (45.8 years) and those without MDD 
(46.9 years) hardly differed; but with respect to their current living situation, they 
considerably differed: 84.7% of the mothers without and 69.8% of the mothers with MDD 
lived with a partner. The lifetime unemployment rate was 22.1% among mothers without and 
30.6% among mothers with MDD. We found no differences in the educational level (higher 
education [Abitur]: 26.5% of the mothers without and 27.7% of those with MDD) and in the 
current employment status (employed: 74.7% of mothers without and 72.7% of those with 
MDD). The children’s sex did not differ by maternal MDD status (the ratio of female children 
was 50.0% among mothers without and 55.8% among those with MDD). We found almost no 
difference in the mean age at second follow-up between the children of mothers without (18.8 
years) and those of mothers with MDD (18.6 years).  
 
3.3. Associations between MDD characteristics in mothers and children  
 
The rates of MDD with each of the characteristics in the children are presented in Table 2. We 
differentiated between children of mothers with MDD but without the particular characteristic 
(MDD Charac –) and children of mothers with MDD and with the respective characteristic 
(MDD Charac +).  
 
The first line, for example, indicates that severe MDD was present in 4.5% of the children of 
mothers with mild or moderate MDD (but not the severe subtype) and in 14.3% of the 
children of mothers with severe MDD. This means that 95.5% of the children of MDD Charac 
–  and 85.7% of the children of MDD Charac + mothers either had MDD that was not 
classified as severe or did not fulfill the criteria for MDD at all.  
 
We conducted logistic regression analyses to evaluate whether the observed rates of MDD 
with the respective characteristic differed between children of MDD Charac – and those of 
MDD Charac + mothers. These analyses yielded elevated rates of MDD with the respective 
characteristic in children of mothers with than in those of mothers without the same 
characteristic for melancholia (7.9% vs. 1.4%; OR = 8.8; 95% CI = 1.3–56.2) and impairment 
(17.5% vs. 2.6%; OR = 13.9; 95% CI = 1.1–188.6) but also for severity (14.3% vs. 4.5%; OR 
= 5.2; 95% CI = 1.1–24.8) and number of symptoms (11.2% vs. 3.3%; OR = 5.9; 95% CI = 
1.1–29.2).  
 
The estimates remained relatively stable when we additionally controlled for maternal 
sociodemographic variables as presented in the last column of Table 2. Again, the ORs for 
severity, melancholia, and number of symptoms were clearly elevated. Only for impairment, 
the adjusted OR did not reach the required level of significance although the point estimate 
even slightly increased.  
 
No significant interactions with sex of offspring were found, which suggests similar ORs for 
female and male offspring.  
 
4. Comment  
 
The goal of this study was to explore mother–offspring associations of MDD in a community 
sample, taking into account various phenotypic symptom characteristics. In this context, the 
special strengths of the EDSP study are the following: (1) As the children and their mothers 
were drawn from the general population, selection bias due to treatment seeking can be ruled 
out. (2) Direct and independent diagnostic interviews were conducted with all participants, 
excluding informant bias. (3)MDD and its characteristics were assessed in mothers and 
children with a standardized interview. (4) Detailed information on a variety of MDD 
characteristics in probands and their family members was available.  
 
First, we could demonstrate that all of the characteristics of MDD examined (severity, number 
of symptoms, recurrence, early onset, suicidality, melancholia, treatment, impairment, 
comorbidity with anxiety disorders) occur frequently in both, mothers and their children. For 
most of these characteristics, rates are similar among 17- to 21-year-old children (mean age: 
18.5 years) and their mothers. This further supports the notion that the core phenotypic 
expressions of depression in general is quite similar among adolescents and adults (Roberst et 
al., 1995; Birmaher et al., 1996; Oldehinkel et al., 1999; Kessler et al., 2001; Lewinsohn et al., 
2003, see, however, Weiss and Garber, 2003). We showed that about 50% of the mothers and 
children with MDD had at least one comorbid anxiety disorder, a finding that is in line with 
reports from other community studies (e.g., Angold et al., 1999; Axelson and Birmaher, 2001; 
Kessler, 2001; Andrade et al., 2003; see also Wittchen et al., 2000, 2003). Despite the general 
assumption that impairment and suicidality increase with age (Birmaher et al., 1996), we 
found high rates of suicidality (>40%) and impairment (>80%) in both groups. However, 
although almost two thirds of the mothers reported to have been in treatment for their 
depression, the respective rate in adolescents was only about 24%. Similarly, the rate of 
melancholia found in mothers was about twice that in their children, indicating that a 
melancholic symptom profile might be more likely in higher ages. This would be in line with 
the report by Birmaher et al. (2004), who found more melancholic symptoms in adolescents 
than in children. Like other studies, we could not demonstrate different characteristics of 
MDD among male and female participants (Haarasilta et al., 2001; Lewinsohn et al., 2003).  
 
The second part of this study dealt with the question of whether mothers and their children 
(given that both fulfill the lifetime criteria for MDD) resemble each other with respect to the 
clinical characteristics of the disorder. For severity as well as for both of the components used 
to define severity (i.e., number of symptoms and impairment, see DSM-IV, APA, 1994), the 
analyses revealed elevated rates of the same characteristic in the children of mothers with the 
respective feature, with high ORs ranging between 5.2 (severity) and 13.9 (impairment). In 
addition, higher rates of MDD with melancholic features were found in the children of 
mothers with melancholia (OR = 8.8). For the other characteristics (recurrence, early onset, 
suicidality, treatment, and comorbid anxiety disorder), no differences could be demonstrated.  
 
Thus, we found mother–offspring associations for severity, number of symptoms, impairment, 
and melancholia. Maternal sociodemographics could not explain our associations, since 
controlling for these variables did not change the estimates of the ORs substantially. Although 
we found several significant associations, the broad confidence intervals did not allow us to 
assess the actual magnitudes of these relations. The rather small number of mother–child pairs 
with MDD prevented stable estimations. Also, the low statistical power indicates that for the 
negative findings the presence of moderate – and sometimes strong – associations cannot be 
ruled out. The failure to demonstrate associations with recurrence, treatment, and early onset 
might also be attributed to the fact, that the offspring by definition all have a fairly early onset 
and have not yet gone through a sufficient long period of risk for depression.  
 
In the present study, we could demonstrate for mothers and their children an aggregation of 
clinical characteristics of MDD, whereas Klein et al. (2002) did not find any indication of a 
familial aggregation of MDD characteristics in young adults and their families. However, in 
line with the results of the present study, for example, Kendler et al. (1992) reported 
significant correlations in twins for impairment and number of symptoms. Although 
Weissman et al. (1984) and Wickramaratne and Weissman (1998) showed higher rates of 
early-onset MDD in relatives of probands who themselves reported an early onset of the 
disorder, this result was not found in the present study or in the analyses of Klein et al. (2002) 
or Maier et al. (1991). Thus, our results further underline the possibility that early-onset MDD 
might be associated with familial aggregation to a lower degree than it was previously 
assumed (see Sullivan et al., 2000; Merikangas et al., 2002). However, cut-off points for 
early-onset MDD vary considerably among and also within studies. For example, our cut-off 
point was set at age 30 for mothers and 15 for offspring. Due to the relatively young age of 
the latter, the age distribution was truncated, leaving open the possibility for early-onset MDD 
to aggregate in families if a later cut-off point is chosen. To our knowledge, our results are – 
compared to those from previous studies – the only ones based solely on direct interviews 
with probands and family members in a representative community sample.  
 
Because patterns of familial transmission have been conceptualized as one important validator 
of diagnostic subtypes (Robins and Guze, 1970; Andreasen et al., 1986; Weissman et al., 
1986a,b; Kendell, 1989; Merikangas, 2002), our results can be interpreted as a validation 
especially of the DSM-IV (APA, 1994) subtype classifications of MDD according to severity 
and melancholia. In particular, melancholic features seem to „breed true“ within families 
because rates of melancholia were higher in children of mothers with melancholia than in 
children of mothers with most of the other characteristics (results are not presented but are 
available on request). This finding supports the conclusions of previous reports that the 
concept of melancholia has „some clinical utility and some validity“ (Rush and 
Weissenburger, 1994; Türkçapar et al., 1999; Klein et al., 2002; see, however, Parker, 2000; 
Joyce et al., 2002). As a rather surprising finding, we found no mother–offspring association 
for recurrent MDD, which, again, may have been due to the young age of our study sample. 
Under the assumption that children with prepubertal and adolescent onset MDD might have 
recurrent MDD in adulthood (Pine et al., 1998; Lewinsohn et al., 1999; Weissman et al., 
1999; Fombonne et al., 2001), this result might be considered transient.  
 
There is widespread agreement that, due to the phenotypic heterogeneity of MDD, research 
regarding the etiology (e.g., risk factors, pathophysiology, genetics) as well as the treatment 
of MDD requires, first of all, the definition of more homogeneous subgroups of MDD (e.g., 
Kaufman et al., 2001; Drevets, 2002; Merikangas, 2002). Such definitions might allow, for 
example, for the differentiation between familial and nonfamilial forms of the disorder. One 
possibility of doing so is to study the patterns of familial transmission. Our findings, which 
demonstrate for mothers and their children an aggregation of severity, impairment, number of 
symptoms, and melancholia, can be considered as an important step towards the search for 
more homogeneous subgroups, indicating that MDD with these features may constitute 
familial forms of the disorder.  
 
However, it is crucial to realize that the characteristics that we examined are not mutually 
exclusive but overlapping. Faravelli et al. (1996), among others, reported that depressed 
patients with melancholia differed from those without melancholia regarding number of 
symptoms, severity of the disorder, and impairment. Thus, it remains unclear, for example, 
whether our observed aggregation is specific to melancholia or rather to symptom severity or 
impairment (see also Kendler, 1997; Türkçapar et al., 1999; Parker, 2000). Unfortunately, the 
number of mother–child pairs in this study was too small as to allow for additional multiple 
models needed to identify core features transmitted between mothers and their children 
(Merikangas, 2002).  
 
The results of our study imply that, to a certain extent, an individual’s familial background 
can influence the clinical characteristics of MDD displayed when a person has MDD. What 
mechanisms might be involved in this observed resemblance of MDD characteristics? Twin 
studies support the hypothesis that genetic factors may play some role, although familial–
environmental factors also seem to be of considerable importance (Kendler et al., 1992; 
McGuffin et al., 1996; Kendler, 1997). However, more research is needed to answer this 
question.  
 
With respect to the limitations of the study, the following issues have to be considered. First, 
information on MDD and its characteristics within families is available only on mothers and 
their children. Therefore, conclusions regarding the familial transmission of MDD and its 
characteristics are limited to mother–child associations. They are specific to the resemblance 
of characteristics of MDD between mothers and their children and do not allow for 
generalizations onto the transmission within families in general. Second, information of 
mothers and children is based on direct interviews only. Generally speaking a multimethod 
approach integrating information from different sources (e.g., best-estimate diagnoses based 
on direct interviews, informant information and medical records) may result in more valid 
diagnoses (Kendler and Roy, 1995). With respect to the clinical features of depression, 
however, Parker et al. (1992, 2003) demonstrated good agreement between self-reported and 
psychiatrist-rated measures but a clear lack of validity regarding reports of family members. 
Therefore, we assume that using direct interview information only still allows for valid 
assessment of the clinical features of depression. Third, children have not passed through the 
entire risk period for onset of MDD. Therefore, the results cannot yet be considered as robust. 
It can be assumed that the inclusion of false-negative cases (i.e., children that have not yet 
developed MDD) resulted rather in an underestimation of the respective associations. Also, 
these results apply only to adolescents until the age of 21, as, so far, no data are available on 
the development afterwards.  
 
In conclusion, mothers and their children with MDD tend to resemble each other regarding 
melancholia, impairment, severity, and number of symptoms. This finding might help to 
differentiate between familial and non-familial forms of MDD and might improve etiological 
research as well as intervention strategies. Further research should clarify possible core 
features transmitted within families as well as the mechanisms underlying this transmission.  
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